Authors:
Sanduleanu, S
Jonkers, D
de Briune, A
Hameeteman, W
Stockbrugger, RW
Citation: S. Sanduleanu et al., Changes in gastric mucosa and luminal environment during acid-suppressive therapy: A review in depth, DIG LIVER D, 33(8), 2001, pp. 707-719
Authors:
Sanduleanu, S
Jonkers, D
De Bruine, A
Hameeteman, W
Stockbrugger, RW
Citation: S. Sanduleanu et al., Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis, ALIM PHARM, 15(8), 2001, pp. 1163-1175
Authors:
Sanduleanu, S
Jonkers, D
De Bruine, A
Hameeteman, W
Stockbrugger, RW
Citation: S. Sanduleanu et al., Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa, ALIM PHARM, 15(3), 2001, pp. 379-388
Authors:
Salvarani, C
Vlachonikolis, IG
van der Heijde, DM
Fornaciari, G
Maechioni, P
Beltrami, M
Olivieri, I
Di Gennaro, F
Politi, P
Stockbrugger, RW
Russel, MG
Citation: C. Salvarani et al., Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients, SC J GASTR, 36(12), 2001, pp. 1307-1313
Authors:
Schoon, EJ
Muller, MCA
Vermeer, C
Schurgers, LJ
Brummer, RJM
Stockbrugger, RW
Citation: Ej. Schoon et al., Low serum and bone vitamin K status in patients with longstanding Crohn's disease: Another pathogenetic factor of osteoporosis in Crohn's disease?, GUT, 48(4), 2001, pp. 473-477
Authors:
Sanduleanu, S
De Bruine, A
Stridsberg, M
Jonkers, D
Biemond, I
Hameeteman, W
Lundqvist, G
Stockbrugger, RW
Citation: S. Sanduleanu et al., Serum chromogranin A as a screening test for gastric enterochromaffin-likecell hyperplasia during acid-suppressive therapy, EUR J CL IN, 31(9), 2001, pp. 802-811
Authors:
Geerling, BJ
Badart-Smook, A
van Deursen, C
van Houwelingen, AC
Russel, MGVM
Stockbrugger, RW
Brummer, RJM
Citation: Bj. Geerling et al., Nutritional supplementation with n-3 fatty acids and antioxidants in patients with Crohn's disease in remission: Effects on antioxidant status and fatty acid profile, INFLAMM B D, 6(2), 2000, pp. 77-84
Authors:
Kremers, SPJ
Mesters, I
Pladdet, IE
van den Borne, B
Stockbrugger, RW
Citation: Spj. Kremers et al., Participation in a sigmoidoscopic colorectal cancer screening program: A pilot study, CANC EPID B, 9(10), 2000, pp. 1127-1130
Authors:
Geerling, BJ
Badart-Smook, A
Stockbrugger, RW
Brummer, RJM
Citation: Bj. Geerling et al., Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls, EUR J CL N, 54(6), 2000, pp. 514-521
Authors:
Schoon, EJ
van Nunen, AB
Wouters, RSME
Stockbrugger, RW
Russel, MGVM
Citation: Ej. Schoon et al., Osteopenia and osteoporosis in Crohn's disease: Prevalence in a Dutch population-based cohort, SC J GASTR, 35, 2000, pp. 43-47
Authors:
Witte, J
Shivananda, S
Lennard-Jones, JE
Beltrami, M
Politi, P
Bonanomi, C
Tsianos, EV
Mouzas, I
Schulz, TB
Monteiro, E
Clofent, J
Odes, S
Limonard, CB
Stockbrugger, RW
Russel, MG
Citation: J. Witte et al., Disease outcome in inflammatory bowel disease: Mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD), SC J GASTR, 35(12), 2000, pp. 1272-1277
Citation: Ej. Schoon et al., Bone mineral density in patients with recently diagnosed inflammatory bowel disease, GASTROENTY, 119(5), 2000, pp. 1203-1208
Authors:
Vrij, AA
Rijken, J
van Wersch, JWJ
Stockbrugger, RW
Citation: Aa. Vrij et al., Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis, EUR J CL IN, 30(3), 2000, pp. 188-194
Authors:
Bragelmann, R
Armbrecht, U
Rosemeyer, D
Schneider, B
Zilly, W
Stockbrugger, RW
Citation: R. Bragelmann et al., The effect of pancreatic enzyme supplementation in patients with steatorrhoea after total gastrectomy, EUR J GASTR, 11(3), 1999, pp. 231-237
Citation: Bj. Geerling et al., Gender specific alterations of body composition in patients with inflammatory bowel disease compared with controls, EUR J CL N, 53(6), 1999, pp. 479-485